Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emi Sugimoto

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Haematologica|September 21, 2023
Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemiaYuta Kaito, Emi Sugimoto, Fumi Nakamura, et al.
Cancer Science|August 11, 2025
Machine Learning-Based Predictive Modeling Maximizes the Efficacy of mTOR/p53 Co-Targeting Therapy Against AMLJingmei Li, Emi Sugimoto, Keita Yamamoto, et al.
Cell Reports|August 3, 2024
SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiationYu-Hsuan Chang, Keita Yamamoto, Takeshi Fujino, et al.
Communications Biology|December 22, 2023
Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemiaEmi Sugimoto, Jingmei Li, Yasutaka Hayashi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Haematologica|September 21, 2023
Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemiaYuta Kaito, Emi Sugimoto, Fumi Nakamura, et al.
Cancer Science|August 11, 2025
Machine Learning-Based Predictive Modeling Maximizes the Efficacy of mTOR/p53 Co-Targeting Therapy Against AMLJingmei Li, Emi Sugimoto, Keita Yamamoto, et al.
Cell Reports|August 3, 2024
SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiationYu-Hsuan Chang, Keita Yamamoto, Takeshi Fujino, et al.
Communications Biology|December 22, 2023
Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemiaEmi Sugimoto, Jingmei Li, Yasutaka Hayashi, et al.
Pageof 1